TU Delft – Assistant Professor Bioinformatics for Human Diseases

Job description
You will head the bioinformatics for human diseases research theme and its associated educational activities. Within this theme we aim to improve the understanding of human diseases, from biomarker discovery to mechanistic understanding of disease progression, with the ultimate aim of contributing to the design of precision medicine. Challenges relate to integrating genomics data (across difference levels of cellular regulation), deciphering heterogeneity in cells (in space and across time), exploiting physical properties of the cell (such as the 3D organisation of DNA), and rich, longitudinal phenotyping of patients (from medical records and imaging to wearable sensors). You will initiate your own research lines within this context, design the necessary pioneering bioinformatics methodologies, and apply these to impact the medical domain. You will do so as principal investigator, leading day-to-day research activities of your team, fostering creativity and scientific excellence, and initiating collaborations with internationally leading labs. In addition, you will contribute to courses at the BSc, MSc and PhD levels in the Computer Science, Life Science Technology and Nanobiology programmes of the TU Delft. In short, you will show leadership in bioinformatics for human diseases, be active in the relevant international communities, and set internationally recognised research directions.

You have a PhD in bioinformatics or a related discipline, a strong track record demonstrated by well-cited publications in top journals, and affinities for machine learning/data science and human diseases. You are motivated, enthusiastic, and decisive, and you work effectively in a multidisciplinary team. You motivate peers and students to share your enthusiasm for your science. Your English is fluent with excellent writing skills. You are an inspiring teacher with a track record in undergraduate/graduate teaching programmes (teaching certificates are considered an advantage).

Read more